Medicine decision-making delays are affecting patients, pharmacists and the broader healthcare system, a professional body argues Lags in adopting new medicines and treatments are often felt by pharmacists on the frontline, with consequences for adherence, continuity of care, patient care and clinical outcomes, the head of a professional body says. While caution is a necessity This content is restricted to registered users only.